We are excited to share that fme will be joining the 12th Master Data and Data Governance Excellence In Life Sciences Conference, 4-5 June in Zurich, Switzerland. In the Life Sciences industry, data is no longer just an operational asset, it is the foundation for innovation, regulatory compliance, and commercial success. fme’s experts look forward to participating in these discussions to share our experience and strategies to rescue information from disconnected silos and align it with business goals.
Today, data is no longer a by-product of operations. It is a strategic asset that underpins innovation, regulatory compliance, and commercial success.
Across Regulatory, Clinical, Quality domains, organizations are entering a new data reality. Regulatory expectations, such as IDMP, are accelerating the need for structured, standardized, and interoperable data. At the same time, governance is evolving from control to enablement, where data must actively support processes, analytics, and decision-making. In addition, new AI solutions show amazing promise but are only as effective as the data they are built on.
This shift is redefining long-standing concepts. The idea of a single, static source of truth is giving way to dynamic, connected, and context-driven data ecosystems that must work seamlessly across systems and functions.
The Gap Between Ambition and Execution
Many organizations are investing in AI use cases, data governance frameworks, and master data management initiatives. However, execution remains a challenge.
- Data is often not AI-ready.
- Quality issues limit trust and reuse.
- Governance frameworks exist but are not embedded in daily operations.
- MDM approaches struggle to scale across domains and keep pace with increasing complexity.
This creates a disconnect between strategy and reality. Without trusted and governed data, transformation initiatives slow down, risk increases, and expected value is not fully realized.
How fme Translates Data Strategy into Execution
At fme, we help Life Sciences organizations turn data ambition into execution. Our approach focuses on building trusted data foundations that support transformation across the full lifecycle:
Data readiness and assessment
We help organizations understand their data landscape through system inventory, quality analysis, and risk identification. This creates clarity before transformation begins.
Master data and governance enablement
We support the design and operationalization of governance frameworks, including data ownership, metadata standards, and harmonization across domains. The focus is on making governance actionable in daily work.
Migration and transformation execution
With deep expertise in platforms such as Veeva Vault, Generis CARA, Documentum, and TrackWise, fme delivers controlled and compliant migrations. Our migration-center® technology enables scalable, repeatable, and auditable execution.
Data quality and remediation
We support ongoing data quality improvement, remediation, and post-go-live stabilization to ensure data remains trusted, usable, and aligned with evolving requirements.
A Practical Path Forward
Success in this new data reality requires more than technology. It requires scalable governance, high-quality data, and the ability to operationalize master data across domains.
fme combines domain expertise, proven methodology, and purpose-built technology to help organizations reduce risk, improve efficiency, and unlock the full value of their data.
Meet Us at the Conference
We look forward to connecting at the 12th Master Data and Data Governance Excellence in Life Sciences Conference and discussing how Life Sciences organizations can move from ambition to execution.
If you are navigating data complexity, regulatory pressure, or AI readiness, let’s connect. We’d love to discuss your challenges, and share our proven strategies and solutions to complex information management challenges.
fme AG
fme SRL
